Press Releases Alkermes plc

Equities

ALKS

IE00B56GVS15

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
24.15 ^USD	-1.27%		+0.42%	-12.94%

May. 02	UBS Adjusts Price Target on Alkermes to $21 From $23, Maintains Sell Rating	MT
May. 01	Alkermes's Q1 Earnings, Revenue Grow But Miss Street View	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk	May. 02	PR
Alkermes : Q1 2024 Earnings Call Script FINAL 5 1 2024	May. 02	PU
Alkermes : ALKS Q1 2024 Earnings Slides FINAL 5 1 2024	May. 02	PU
Alkermes: Q1 Earnings Snapshot	May. 01	AQ
Alkermes plc Reports First Quarter 2024 Financial Results	May. 01	PR
Alkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 1	Apr. 24	PR
Alkermes to Report First Quarter Financial Results on May 1, 2024	Apr. 17	PR
Alkermes Announces Positive Topline Results from Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients with Narcolepsy Type 2 and Idiopathic Hypersomnia	Apr. 10	AQ
BlackBerry, Alkermes rise; Neogen, Tilray Brands fall, Tuesday, 4/9/2024	Apr. 09	AQ
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors	Mar. 07	PR
Alkermes: Q4 Earnings Snapshot	Feb. 15	AQ
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2023 and Provides Financial Expectations for 2024	Feb. 15	PR
Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 15, 2024	Feb. 08	PR
Alkermes Announces Topline Results from Long-Term, Open-Label Safety and Durability of Treatment Effect Study of LYBALVI	Jan. 04	AQ
Alkermes to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Jan. 03	PR
Alkermes plc Announces Agreement to Sell Athlone, Ireland Facility to Novo Nordisk	Dec. 14	PR
Alkermes to Participate in Two Upcoming Investor Conferences	Nov. 21	PR
Alkermes Completes Separation of Oncology Business	Nov. 15	PR
Alkermes to Participate in the Jefferies London Healthcare Conference	Nov. 07	PR
Alkermes Announces Effectiveness of Mural Oncology Form 10 Registration Statement	23-10-31	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Alkermes plc

Equities

ALKS

IE00B56GVS15

Press Releases

Filters